Cover page

1
Executive summery
With a focus on healthcare for individuals, AstraZeneca PLC develops and markets pharmaceutical
products. The organization's main goals are the research, development, production, and marketing of
pharmaceuticals for medical purpose. Oncology, Biopharmaceuticals (including Cardiovascular, Renal, and
Metabolism (CVRM), and Respiratory, and Immunology (R&I), and Rare Disease are some of the areas of
emphasis for the company. It has a diverse portfolio of therapeutic candidates in different phases of clinical
development, which makes up its pipeline. The Alexion Rare Disease portfolio is a part of their pipeline of 177
products, 161 of which are under clinical testing at this time. Tagrisso, Lynparza, Imfinzi, Koselugo ,
Farxiga/Forxiga, Roxadustat, Onglyza, and others are some of the company's most successful cancer drugs. The
United Kingdom, the rest of Europe, the Americas, and Asia, Africa, and Australasia are the four regions that
make up the Company's geographical segments.

Contents
2
Executive summery...............................................................................................................................................................2
01. Introduction to organization...........................................................................................................................................3
1.1 History......................................................................................................................................................................... 4
1.2 Vision........................................................................................................................................................................... 4
1.3 Mission........................................................................................................................................................................ 4
1.4 Products...................................................................................................................................................................... 4
02. International strategy of AstraZeneca.............................................................................................................................5
2.1 What is international strategy.....................................................................................................................................5
2.2 Current international strategy of AstraZeneca............................................................................................................6
2.3 Evaluation of current international strategy...............................................................................................................6
03. Global challenges that may affect international expansion and recommendations for tackle challenges......................8
3.1 Global Challenges........................................................................................................................................................8
3.2 Recommendations......................................................................................................................................................8
04. Suitable new markets to enter......................................................................................................................................10
4.1 What is new market..................................................................................................................................................10
4.2 New markets to enter...............................................................................................................................................10
4.3 Justification...................................................................................................................Error! Bookmark not defined.
05. Suitable entry mode......................................................................................................................................................14
5.1 Justification............................................................................................................................................................... 14
References.......................................................................................................................................................................... 16

01. Introduction to organization

3
 Cambridge, England is home to the global headquarters of AstraZeneca plc, a British-Swedish
pharmaceutical and biotechnology corporation. It offers a variety of treatments for serious conditions, includ

4
as cancer, heart disease, digestive issues, infections, neurological disorders, respiratory issues, and inflammation.
It has contributed to the creation of the COVID-19 vaccine developed by Oxford and AstraZeneca. (wikipedia,
2022)

When the Swedish Astra AB and the British Zeneca Group merged in 1999, the resulting firm was
established. Since the merger, it has become one of the biggest pharmaceutical firms in the world and has
acquired other smaller businesses, including Cambridge Antibodies Technology (2006), Medimmune (2007),
Spirogen (2013), and Definiens (2016). (by Medimmune in 2014). Cambridge, England, Gothenburg, Sweden,
and Gaithersburg, Maryland, in the United States serve as its three main research and development hubs. The
pharmaceutical giant AstraZeneca is included in the prestigious FTSE 100 Index and is listed on the London
Exchange as its major trading venue. (wikipedia, 2022)

1.1 History
Astra AB was established in 1913 in Sodertalje, Sweden, by four hundred apothecaries and medical
professionals. Zeneca Group PLC was created in 1993 as a result of the demerger of ICI's pharmaceuticals
division, as well as its agrochemicals and specialties businesses. ICI had been established in the previous year as
a result of the merger of four British chemical corporations. A final merger between Astra and Zeneca Group
took place in 1999, resulting in the formation of AstraZeneca plc, which has its London headquarters.
AstraZeneca chose the "Fairfax-plus" property in North Wilmington, Delaware, as the new home for the
company's headquarters in the United States in the year 1999. (wikipedia, 2022)

1.2 Vision
“Our goal is to develop treatments that are effective against all types of cancer. We were following the
research to better comprehend cancer and all of its intricacies in order to find, develop, and provide medicines
that can change people's lives and raise the likelihood of curing the disease”. (astrazenca, 2022)

1.3 Mission
We hope to revolutionize healthcare, improve the quality of life for billions of people, and find solutions
to some of the most intractable problems in the field of medicine that now face humanity. Our goal is to halt the
progression of these frequently life-threatening, debilitating, and degenerative illnesses, induce remission in
affected individuals, and ultimately find a treatment for them. (astrazenca, 2022)

1.4 Products
1. Andexxa coagulation factor

5
2. Kombiglyze tablets

3. Bevespi aerosphere

4. Lokelma

5. Lynpazra tablets

02. International strategy of AstraZeneca

2.1 What is international strategy
Exporting or importing products and services while having a corporate headquarters or locations in their
home country is an example of an international strategy. This strategy is often the first step that most
organizations
6
take when expanding their operations to a worldwide scale. The process of global growth of a corporation
cannot be reduced to a single, generic strategy. (smartling, 2022)

2.2 Current international strategy of AstraZeneca

According to the company's official mission statement, AstraZeneca's goal is "to make a substantial
impact to patient health via exceptional medicines that deliver benefit to patients and generate value for the
parties involved and society." The company has devised a strategy to achieve this objective, and it entails a
number of key directions. These directions are intended to ensure excellent productive capacity in R&D
(research & innovation), continued to increase specialist co - ops, global alignment, stronger customer
orientation, and operating excellence with a flexible cost basis. They already are contributing to the third
Sustainable Development Goal of the United Nations, which is "Good Health and Well-Being." The
underpinnings of the business model are firmly established in sustainability, and by providing healthcare to
thousands of people, they are contributing to that goal. (sun, 2013)

In addition, AstraZeneca has three primary objectives when it comes to responsibility and sustainability.
These are illustrated in the infographic, and they concentrated on limiting their influence on the environment,
expanding the amount of healthcare that is supplied throughout the world, and encouraging ethics and openness
in all communities. The pharmaceutical sector is now through a period of fast transformation and globalization,
and it is being continuously influenced by the dynamic changes that are taking place in the market.
AstraZeneca, like all other firms operating in this sector, is subject to the same industry changes as everyone
else: For instance, the company's present business strategy involves joint ventures from the laboratory to the
pharmacy. However, the company is transitioning toward a model that is more fragmented, with diverse actors
working in all parts of the value chain. The operational and commercial models that pharmaceutical firms have
traditionally used have been known to be notoriously difficult to understand. (sun, 2013)

2.3 Evaluation of current international strategy

In the field of international business studies, one of the most important topics to discuss is the
globalization of companies. The pharmaceutical sector is mostly controlled by multi-national corporations. The
world's top corporations often have their headquarters in only a few of countries, the most prominent of which
are the United States of America, the United Kingdom, Japan, France, Germany, and Switzerland. All of the big
corporations run significant businesses in a number of different nations. Research and development (R&D)
efforts still have a tendency to be centered in a small number of nations, although marketing and sales units are
dispersed over the globe. Research and advancement (R&D) is the cornerstone of the business, and
practically all novel
7
pharmaceutical products are the direct outcome of research conducted by private companies. The various
pharmaceutical businesses' capacity to develop new innovations that really are patentable and that can generate
new medications and pharmaceuticals is a primary factor in the competitiveness of each of these companies in
the industry. Long-term success needs a consistent flow of new treatments and medications, at least some of
which must earn significant profits as they are sold in order to fund the huge expenditures of research and
development. According to Górak-Sosnowska (2016), this suggests that the pharmaceutical sector is an industry
that has a high degree of originality in comparison to other industries. Another distinguishing feature is that a
significant portion of the company's income is invested in its research and development efforts. (sun, 2013)

8
03. Global challenges that may affect international expansion and recommendations for
tackle challenges
3.1 Global Challenges
1. The pharmaceutical firm has a lot of challenges due to its management philosophy, but the biggest obstacle is
overseas receptivity. Increasing competition has caused the company to rethink its target market strategies and
contemplate expanding into other industries. The company has struggled with customer loyalty and product
acceptance. Many potential clienteles chose home-based service providers over AstraZeneca, Sun (2013) said.
Similar challenges have been experienced by other companies when entering into other countries. New
countries choose non-Western medicines. AstraZeneca's aim to be a global leader in medicine has been
hindered. (sun, 2013)

2. Diplomatic contacts have compounded the company's overseas issues. These little disharmonies affect
people's purchasing habits. Some Islamic countries dislike European and North American drugs. Cultural and
religious differences worsen these nations' unfavorable connections. India and Cuba choose domestic
medication over imported due to bad ties. Large corporations like AstraZeneca confront severe competition at
home and abroad. Chinese people' reluctance to buy pharmaceuticals from Europe and the U.S. is an example of
how weak diplomatic relations hurt AstraZeneca. These problems have slowed the company's expansion.
(Mordock, 2016)

3. Generic competition has hurt the firm recently. After rivals produced cheaper alternatives for several of its
top medications, they became obsolete. Nexium treats gastrointestinal issues, Seroquel is an antipsychotic, and
Crestor decreases cholesterol, according to Sun (2013). Three medications put the business ahead of Pfizer,
GSK, and Merck. Recent sales declines have hurt these items' market standing. This has also hampered its
efforts to expand to other markets. The above-mentioned medications accounted for over 30% of the company's
sales. A drop in sales meant substantial losses. In an effort to decrease production costs and losses, around 2,300
staff were let off (Sun 2013). The move complicates the company's market expansion goals. (sun, 2013)

3.2 Recommendations
1. In light of the aforementioned difficulties, the company's problems may be solved by implementing the
proposed remedies. The company's dwindling sales and market domination may be reversed with the
appropriate set of instructions. The advantages of downsizing for businesses are many, particularly in hard
economic times. contend that companies can weather economic storms by selling off unnecessary assets and
laying off employees. The method also encourages introspection and the development of novel approaches that
9
may be applied to the

10
current difficulty, which is a great benefit to businesses. The move is crucial for AstraZeneca Inc. since it brings
in new money and frees up resources to pursue other fruitful avenues. (sun, 2013)

2. During downsizing, the corporation issued revenue-generating medications. Lynparza and Tagrisso joined the
business when it restructured operations and staff. These medications helped the pharmaceutical industry
survive. The move is vital and prudent, particularly in current times when generic and mainstream opponents
are fierce. Market scrutiny directs pharmaceutical management's efforts. Without proper preparation, these
companies may face problems like AstraZeneca. Poor planning from management led to overdependence on
specific medications, and the corporation suffered large losses. (Mordock, 2016)

3. If the company prioritizes actions that enable it thoroughly assess market developments, it will face
comparatively few of these difficulties. The company's ability to innovate in the face of formidable rivals will
be considerably aided by a thorough understanding of current pharmaceutical industry trends. These efforts are
crucial even for businesses in unrelated industries. insists that businesses can't survive the intricacies of today's
marketplace without strong R&D initiatives. Therefore, AstraZeneca Inc. must enhance its R&D operations to
comprehend the ever-altering customer patterns and new methods of managing competition if it is to
successfully meet the current issues. (Mordock, 2016)

11
04. Suitable new markets to enter
4.1 What is new market
If your product allows a big number of consumers to perform a task they were previously unable to do,
then you have successfully established a new market for that product. When entering a new market, both the
consumers and their tastes are a mystery, and there are no direct competition to contend with. (marsdd, 2022)

4.2 New markets to enter

AstraZeneca is undergoing a transition that is pipeline- and sales-driven, and Emerging Markets play a
crucial role in this development. Over the course of the past few years, our worldwide sales base has shifted
from one in which the majority of our revenue was generated from products that we now refer to as "Other"
medicines to one in which the majority of our efforts are currently concentrated on three primary therapeutic
categories: cancer, new cardiovascular, renal and metabolic, and respiratory. Emerging Markets are now doing
better than the rest of the globe in several therapeutic areas. (astrazenca, 2022)

After considering all the factors, I suggest Bangladesh as a new market. The reasons are the following,

1. Political factors- Bangladesh is trying to strengthen its connections with other countries.

Bangladesh won its independence from Pakistan in 1971 after a bloody nine-month war. There have been
significant changes in the political landscape of Bangladesh since then. Bangladesh, like many other developing
countries, was ruled by a military junta during the years 1975 and 1990. During this period, the liberal
constitution was abandoned naturally to appease the military. During this period, Islam was officially declared
the state religion, and religiously motivated politics were commonplace. For a while, religious political parties
were unable to operate in the secular country of Bangladesh, but that changed about this time. As a result of a
military coup in 1990, a caretaker government assumed power. After that, the Awami League (AI) and
Bangladesh National Party (BNP) continued to struggle for democratic leadership of the country. (MOMIN,
2020)

 Deals with India

The covid-19 epidemic has had a devastating impact on the developing nations of Southeast Asia.
Therefore, on 25 July 2020, both nations declared a collaboration to unite their efforts in recovery due to
their similar interests, history, and culture. Obviously, when the two nations join troops to fight their
fights, they can't help but win. There is a lot that the two nations can learn from one another, and many
different fields and businesses both in countries will flourish as a result. (MOMIN, 2020)

12
 Results in Bangladesh and the Joe Biden Campaign:

13
The market has varying forecasts for the future of partnership between the two nations while Biden is in office.
Members of Bangladesh's ruling party (the Awami League) believe the relationship would grow and flourish
after Biden's victory, whereas specialists on international relations and current events disagree. Prime Minister
Sheikh Hasina hopes that newly elected Democrats in the United States would show compassion toward
working for the Rohingyas, and the Bangladeshi government is hoping that the United States will increase its
trade and commerce with Bangladesh. (MOMIN, 2020)

2. Economic factors: Pandemic-induced economic growth

Bangladesh's economic development is remarkable given its third-world status. They've eliminated poverty as
well as other social concerns thanks to some of the world's highest development rates. (MOMIN, 2020)

 GDP/Covid-19

Bangladesh's GDP is anticipated to shrink 2% in 2020 due to the epidemic, while the IMF anticipates a 9.5%
gain in 2021! . As a part of the recovery strategy from the epidemic, the PM has announced a package of Tk
72.750 crore (USD 8,573 million) which equates to roughly 2.52% of the country’s entire GDP! The
administration anticipates further stimulus packages and employment in the following days. (MOMIN, 2020)

 Revenue streams

Bangladesh makes a lot from remittances (5% of GDP $16.4 billion in FY19) and garment exports. Most Gulf
State employees transferring money back to Bangladesh are impacted by the reduction in oil prices. Despite
promising remittances during the second epidemic wave, the US has canceled billions of dollars in orders.
(MOMIN, 2020)

 Economy-Boosting Sectors

Bangladesh is the fourth-largest rice producer, yet natural calamities compel them to import rice. Tea, jute,
wheat, sugarcane, tobacco, spices, and fruits also grow. GDP is 13.1% agriculture. Textiles account for 28.5%
of GDP. Services (53.5% of GDP) dominate. Bangladesh is already a major technology exporter, but the
government wants to boost earnings to $5 billion by 2021. (MOMIN, 2020)

3. Social factors: Rich Bangladeshi culture

14
Bangladesh is rich in culture. Architecture, dancing, music, costumes, and more show it. . Bangladesh shares
India's culture. Both nations share music, clothing, and cuisine. (MOMIN, 2020)

 Demographics

The nation has 2.11% of the global population. Bangladesh has 165,424,778 people as of December 13, 2020.
The nation boasts a large young population, which bodes well for future innovation. Only 39.4% of
Bangladesh's population lives in cities. (MOMIN, 2020)

 Languages:

Businesspeople may use English internationally.

 Culture

Bangladesh is a hierarchical culture where younger people must respect elder people due to age. Because
knowledge comes with age, the eldest family members—usually men—make decisions. Businesses and
organizations listen to elderly folks. Most people believe in Shamanism and Fakirs, Muslim faith healers.
Islamic holidays include two Eids, Kabir, Milad-un-Nabi, and Shab-e-Barat. Durga and Kali Puja are Hindu
festivities. The country's greatest strength is its tolerance. (MOMIN, 2020)

4. Technology- Bangladesh's burgeoning IT scene

We've established that Bangladesh's IT community is actively working to take advantage of digitalization; the
country's stated goal is to establish a digital economy by positioning itself as a hub for digital outsourcing on a
global scale. This decision will benefit the people of Bangladesh in several ways, including the creation of new
jobs and the strengthening of the local economy. Freelancing is on the rise, with large nations like Australia, the
United States, and the United Kingdom sending their IT jobs to people in Bangladesh. (MOMIN, 2020)

 Data Center of South Asia

In the 1990s, Bangladesh took the plunge and began exporting technology. Soft goods were their original focus,
but they have expanded into the computer software market. Bangladesh has become a significant IT exporter,
and although India is now their greatest competitor in Southeast Asia, that may soon change. Data Soft is one of
the software firms in the nation, and it presently provides IT services to customers in the Netherlands, Norway,
Finland, England, the European Union, the United States, and Saudi Arabia. (MOMIN, 2020)

15
  Present-day Technological Landscape:

Bangladesh has a few colleges, a research institute, and an industrial sector (to some extent). They need to
increase their research operations to improve their technology and compete worldwide. More hands-on
experience with technology should be a required part of every university's curriculum. Except for a select few,
not all sectors in Bangladesh's economy are technologically illiterate. Bangladesh has to make efforts to
diversify its economy away from its current reliance on international commerce and toward one that is driven by
advances in technology. (MOMIN, 2020)

5. Legal Considerations: Potential Investments from Abroad

From a commercial standpoint, it is beneficial to familiarize oneself with the laws and taboos of a nation.

 Constitutional Law

The country's legal system remains unchanged from when the British ruled the subcontinent. It developed
throughout time by absorbing elements of both English and Mughal culture. They have both Hindus and
Muslims serving in government positions. (MOMIN, 2020)

 Investing Abroad

Although foreign investment is generally welcomed, it is restricted from the national defense, forest plantation,
and mining sectors. In reality, to improve the economy and infrastructure, the government actively seeks out
foreign investment in local companies. (MOMIN, 2020)

 No Tax Required

Investors who have made a purchase in the Bangladeshi "thrust sector" between July 1, 2019, and June 30,
2024, will be eligible for a tax exemption. The term "thrust" is used to describe any enterprise that helps
advance the industrialization of a nation. Investors might get a tax break of up to 30%, depending on the sector
they put their money into. (MOMIN, 2020)

16
05. Suitable entry mode
The best entering way to Bangladesh market is to come up with partnering with one of biggest medicine
manufacturer in Bangladesh.

5.1 Justification
1. An Opportunity to Collaborate with Pharmaceutical Industry Professionals

If you enter the pharmaceutical sector, you will be presented with several opportunities to network with highly
experienced pharmaceutical industry experts. Conversations with medical professionals and pharmacists
provide an opportunity to get information about the demand for various items. You may study the strategies of
marketing, and you can get many different viewpoints on the pharma industry, both of which will assist you in
growing. Following our advice, make it a habit to stay current on developments in the pharmaceutical industry.

2. Have a Low Minimum Investment

As a result of the significant initial investment required for most firms, many people are understandably
reluctant to go into company ownership at this era of rising prices. However, not all companies are one and the
same; there will always be those that stand out from the crowd. You may start your own company with nothing
more than the items themselves if you want to get into the pharmaceutical sector. You will surely need other
kinds of things, such as capital assets, but you may be able to get started in your job with only a little
investment.

3. Make Market Easily

You will have the ability to start a pharma franchise business with exclusive rights, notwithstanding the size of
your company being either tiny or enormous. You are the only owner of a small company in the neighbourhood.
To put it another way, if you make the right choice in terms of the firm that handles the distribution of the
pharmaceutical franchise on a monopoly basis, your will become the exclusive supplier of innovative, high-
quality goods.

The pharmaceutical industry in Bangladesh is one of the country's most progressive and rapidly
developing industrial sectors. Bangladesh is not only covering the domestic need for pharmaceuticals, but also
generating significant foreign cash via exports. Even though the pharmaceutical business only contributes a
relatively modest amount to GDP, it is anticipated that if Bangladesh is able to maintain this growth, the
pharmaceutical industry's contribution to GDP would climb even higher in the future. Bangladesh's
pharmaceutical business is booming, but the nation needs new policies to keep the trend going.
17
References
astrazenca, 2022. astrazenca. [Online]
Available at: [Link] [Link]#:~:text=Our%20ambition%20is%20to
%20provide,increase%20the%20potential%20to%20cure. [Accessed 7 october 2022].

astrazenca, 2022. astrazenca. [Online]

Available at: [Link]
[Link]/#:~:text=We%20want%20to%20transform%20healthcare,and%20one%20day%20cure%20them.
[Accessed 7 october 2022].

marsdd, 2022. learn marsdd. [Online]

Available at: If your product allows a big number of consumers to perform a task they were previously unable to do,
then you have successfully established a new market for that product. When entering a new market, both the
consumers and their tastes are a mystery, and
[Accessed 7 october 2022].

MOMIN, A., 2020. PESTLE ANALYSIS. [Online]

Available at: [Link] analysis/#:~:text=Bangladesh%20PESTLE%20Analysis%3A
%20Conclusion&text=Despite%20their%20fair%20share%20of, for%20the%20post%2Dpandemic%20situation.
[Accessed 13 november 2022].

Mordock, J., 2016. delaware online. [Online]

Available at: [Link]
decline/93584776/
[Accessed 7 october 2022].

Nguyen, J., 2021. vietnam brefing. [Online]

Available at: [Link]
[Link]/
[Accessed 13 november 2022].

Rahi, A. M. a. A., 2022. ahlawatassociates. [Online]

Available at: [Link]
[Accessed 7 october 2022].

smartling, 2022. smartling. [Online]

Available at: [Link]
[Accessed 7 october 2022].

sun, L., 2013. the motley fool. [Online]

Available at: [Link]
[Link]
[Accessed 7 october 2022].

18
wikipedia, 2022. wikipedia. [Online]
Available at: [Link]
[Accessed 7 november 2022].

19